A intracameral combination of tropicamide, phenylephrine and lidocaine in phacoemulsification

Dhruvil V Nayak, H. Trivedi, Ruchi Prabtani
{"title":"A intracameral combination of tropicamide, phenylephrine and lidocaine in phacoemulsification","authors":"Dhruvil V Nayak, H. Trivedi, Ruchi Prabtani","doi":"10.4102/aveh.v82i1.844","DOIUrl":null,"url":null,"abstract":"Background: Although the benefits of intracameral mydriatics have been established in healthy patients, their safety and efficacy in difficult subjects have yet to be determined.Aim: The aim of the study is to assess the safety and efficacy of topical and intracameral application of a combination of tropicamide, phenylephrine and lidocaine during phacoemulsification surgery.Setting: The study was done at the Department of ophthalmology at the University of Bhavnagar, Gujarat, India.Methods: A total of 50 patients were recruited patients who were operated with phacoemulsification surgery. During the intraoperative period, pupil seize was studied and eventual adverse events have been monitored. Also, comfort reported by patients and surgeons has been investigated.Results: It was observed that the intracameral drug combination did not have any impact on blood pressure, pulse rate as well as did not affect the Intra Ocular Pressure (IOP) dynamics and was successful in maintaining pupil size after its application during surgery.Conclusion: The combination also proved effective as an anaesthetic agent, which was proven by pain score findings, as the patients were comfortable and compliant enough to tolerate cataract surgery.Contribution: The mydriatic and anaesthetic combination is efficient enough used topically and intracamerally to carry out phacoemulsification surgery and has a better safety profile when compared with current practices.","PeriodicalId":7694,"journal":{"name":"African Vision and Eye Health","volume":"304 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"African Vision and Eye Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4102/aveh.v82i1.844","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Although the benefits of intracameral mydriatics have been established in healthy patients, their safety and efficacy in difficult subjects have yet to be determined.Aim: The aim of the study is to assess the safety and efficacy of topical and intracameral application of a combination of tropicamide, phenylephrine and lidocaine during phacoemulsification surgery.Setting: The study was done at the Department of ophthalmology at the University of Bhavnagar, Gujarat, India.Methods: A total of 50 patients were recruited patients who were operated with phacoemulsification surgery. During the intraoperative period, pupil seize was studied and eventual adverse events have been monitored. Also, comfort reported by patients and surgeons has been investigated.Results: It was observed that the intracameral drug combination did not have any impact on blood pressure, pulse rate as well as did not affect the Intra Ocular Pressure (IOP) dynamics and was successful in maintaining pupil size after its application during surgery.Conclusion: The combination also proved effective as an anaesthetic agent, which was proven by pain score findings, as the patients were comfortable and compliant enough to tolerate cataract surgery.Contribution: The mydriatic and anaesthetic combination is efficient enough used topically and intracamerally to carry out phacoemulsification surgery and has a better safety profile when compared with current practices.
在乳化手术中使用托吡卡胺、苯肾上腺素和利多卡因的巩膜内组合物
背景:目的:本研究旨在评估在乳化手术中局部和巩膜内使用托吡卡胺、苯肾上腺素和利多卡因的安全性和有效性:研究在印度古吉拉特邦巴夫纳加尔大学眼科系进行:方法:共招募了 50 名接受乳化手术的患者。方法:共招募了 50 名接受超声乳化手术的患者,对术中瞳孔收缩情况进行了研究,并对最终的不良反应进行了监测。此外,还对患者和外科医生报告的舒适度进行了调查:结果:观察发现,巩膜内药物组合对血压、脉搏没有任何影响,也不影响眼内压(IOP)的动态变化,而且在手术中使用后能成功维持瞳孔大小:结论:该组合作为麻醉剂也证明是有效的,疼痛评分结果也证明了这一点,因为患者在手术中感到舒适和顺从,足以耐受白内障手术:贡献:与目前的做法相比,这种局部和腔内使用的散瞳剂和麻醉剂组合在进行超声乳化手术时非常有效,而且具有更好的安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
African Vision and Eye Health
African Vision and Eye Health Health Professions-Optometry
CiteScore
1.00
自引率
0.00%
发文量
46
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信